Page last updated: 2024-09-03

imatinib mesylate and Cystitis

imatinib mesylate has been researched along with Cystitis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cohen, MH; Dagher, R; Griebel, DJ; Ibrahim, A; Martin, A; Pazdur, R; Scher, NS; Sokol, GH; Williams, GA	1
Ozdemirli, M; Tutuncuoglu, SO; Yanovich, S	1

Other Studies

2 other study(ies) available for imatinib mesylate and Cystitis

Article	Year
U.S. Food and Drug Administration drug approval summaries: imatinib mesylate, mesna tablets, and zoledronic acid. The oncologist, 2002, Volume: 7, Issue:5 Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Benzamides; Bone Neoplasms; Cystitis; Diphosphonates; Drug Approval; Gastrointestinal Neoplasms; Hematuria; Hemorrhage; Humans; Ifosfamide; Imatinib Mesylate; Imidazoles; Mesna; Multiple Myeloma; Orphan Drug Production; Piperazines; Protective Agents; Pyrimidines; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration; Zoledronic Acid	2002
CMV-induced hemorrhagic cystitis as a complication of peripheral blood stem cell transplantation: case report. Bone marrow transplantation, 2005, Volume: 36, Issue:3 Topics: Benzamides; Biopsy; Bone Marrow; Cystitis; Cytomegalovirus; Hemoglobins; Humans; Imatinib Mesylate; Immunohistochemistry; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Piperazines; Platelet Count; Pneumonia; Pyrimidines; Time Factors; Transplantation Conditioning	2005

Article

Year

U.S. Food and Drug Administration drug approval summaries: imatinib mesylate, mesna tablets, and zoledronic acid.

The oncologist, 2002, Volume: 7, Issue:5

Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Benzamides; Bone Neoplasms; Cystitis; Diphosphonates; Drug Approval; Gastrointestinal Neoplasms; Hematuria; Hemorrhage; Humans; Ifosfamide; Imatinib Mesylate; Imidazoles; Mesna; Multiple Myeloma; Orphan Drug Production; Piperazines; Protective Agents; Pyrimidines; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration; Zoledronic Acid

2002

CMV-induced hemorrhagic cystitis as a complication of peripheral blood stem cell transplantation: case report.

Bone marrow transplantation, 2005, Volume: 36, Issue:3

Topics: Benzamides; Biopsy; Bone Marrow; Cystitis; Cytomegalovirus; Hemoglobins; Humans; Imatinib Mesylate; Immunohistochemistry; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Piperazines; Platelet Count; Pneumonia; Pyrimidines; Time Factors; Transplantation Conditioning

2005